“…In the last two decades, our group and others have exploited mononuclear first-row transition-metal complexes containing two labile cis ligands as biomimetic or bio-inspired homogeneous catalysts for a great variety of reactions, such as the oxidation of catechol and cyclohexane (Ferre et al, 2017), the hydrolysis of proteins (Oliveira et al, 2009), phosphodiesters (Scarpellini et al, 2003;Kettenmann et al, 2018) and polysaccharides (Concia et al, 2017), and, more recently, water splitting (Luo et al, 2016). They have also been studied as prodrugs and carrier prototypes for the selective delivery of bioactive substances (Pires et al, 2016;de Souza et al, 2016).…”